Foley & Lardner LLP partner Roger Strode discussed the resurgence of health care dealmaking in the Mergermarket article, “Healthcare M&A in recovery — Dealspeak North America.”
Strode commented that the shift in political leadership at the federal level could lead to less restrictive banking regulations and ease scrutiny on private equity buyers. Combined with the financial pressure health care facilities, Strode said this could fuel increased M&A activity in health care.
Noting the impact of the U.S. Supreme Court’s 2024 decision to overturn the Chevron doctrine, Strode explained “we may see a pullback” in the authority of the Department of Health and Human Services, among other agencies influencing the health care industry. If that happens, he said “companies will feel empowered to do more creative dealmaking.”
